Relationship Between STOP BANG Score and Airway Management
Launched by ZONGULDAK BULENT ECEVIT UNIVERSITY · Nov 28, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • American Society of Anesthesiologists (ASA) I-III
- • Between 18-65 years old
- • Volunteered to participate in the study
- Exclusion Criteria:
- • diagnosed with asthma, COPD, heart failure or coronary artery disease, OSAS
- • morbidly obese (BMI\>45 kg/m2),
- • patients with a history of alcohol or drug addiction
- • women in pregnancy or lactation
- • allergic to the drugs used in the study
About Zonguldak Bulent Ecevit University
Zonguldak Bülent Ecevit University is a distinguished academic institution located in Turkey, dedicated to advancing medical research and education. With a strong emphasis on innovation and collaboration, the university actively sponsors clinical trials that aim to enhance healthcare outcomes and contribute to scientific knowledge. Its multidisciplinary approach fosters a dynamic environment for researchers, clinicians, and students, promoting the development of novel therapeutic interventions and evidence-based practices. Through rigorous ethical standards and a commitment to excellence, Zonguldak Bülent Ecevit University plays a pivotal role in the advancement of medical science and the betterment of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zonguldak, Kozlu, Turkey
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Related articles
Similar Trials